Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2008
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292662 Vaccine Comprising Recombinant Clpp Protein of Streptococcus Pneumoniae
11/27/2008US20080292648 Synthetic agonists of tlr9
11/27/2008US20080292636 Chemokine panec-2 polynuleotides, polypeptides, antibodies and methods of making and using them
11/27/2008US20080292622 Methods of evaluating patients
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292589 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
11/27/2008US20080292580 Treatment of Inflammatory Diseases
11/27/2008US20080292566 Oral composition containing morin
11/27/2008CA2688863A1 Method for pain control
11/27/2008CA2687944A1 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2687415A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008CA2687117A1 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
11/27/2008CA2683288A1 Crystalline and amorphous forms of peptide
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1994936A1 Lactobacilli for the prevention of mastitis and for reducing the risk of allergy in breast-fed infants
11/26/2008EP1994932A1 Use of N-desmethylclozapine to treat human psychosis
11/26/2008EP1994005A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
11/26/2008EP1994003A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them .
11/26/2008EP1994002A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
11/26/2008EP1993593A1 Pharmaceutical compositions comprising sods and prolamine based peptide fragments
11/26/2008EP1993572A2 Methods of treating or preventing sinusitis with oxidative reductive potential water solution
11/26/2008EP1993571A2 Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
11/26/2008EP1993570A2 Methods of treating or preventing peritonitis with oxidative reductive potential water solution
11/26/2008EP1993564A1 Method and composition for treating allergic diseases
11/26/2008EP1993544A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
11/26/2008EP1993534A1 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity
11/26/2008EP1993525A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
11/26/2008EP1993524A1 The use of bupropion metabolites for the treatment of inflammatory disorders
11/26/2008EP1993383A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation
11/26/2008EP1763528B1 Pyrazolopyridine derivatives
11/26/2008EP1515736B1 Compositions against inflammatory processes
11/26/2008EP1506162B1 Synthesis of benzonitriles and benzimidates
11/26/2008EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
11/26/2008EP1480595B1 Use of esters of long-chain fatty acids for treatment of autoimmune diseases
11/26/2008EP1473300B1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008EP1328267B1 Method of treating cancer using dithiocarbamate derivatives
11/26/2008CN101312979A Pyrimidine compounds for the treatment of inflammatory disorders
11/26/2008CN101312977A Fused heterocyclic compounds useful as kinase modulators
11/26/2008CN101312976A Spirocyclic compounds as hdac inhibitors
11/26/2008CN101312974A Pyrazoloisoquinoline derivatives
11/26/2008CN101312746A Preparation containing iron(iii)-complexes and redox substances
11/26/2008CN101312730A Pharmaceutical compositions comprising buprenorphine
11/26/2008CN101311193A Complexes using recombined triple helix support as base
11/26/2008CN101311187A Tripterine derivate, preparation method and use thereof
11/26/2008CN101310756A Infused medicine for treating winddampness, neck, shoulder, waist, leg, itai-itai disease
11/26/2008CN101310745A Extracting method of Guangdong purple beautyberry total flavone part
11/26/2008CN101310730A Use of clostridium butyricum for preparing microbiological preparation for preventing and curing atrophic arthritis, ankylosing spondylitis
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436462C Reaction method of biological alkali, reaction product and use thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436449C Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'bipiperidine as ccr5-antagonists for the treatment of aid
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100436427C Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/26/2008CN100435821C Medicine for treating rheumatoid disease
11/26/2008CN100435819C Method for preparing compound corydalis amabilis preparation
11/26/2008CN100435815C Medicine composition for treating pain and preparing method therefor
11/26/2008CN100435814C Scullcap stem and leaf injection powder and its preparing method
11/26/2008CN100435813C Series medicines for treating headache
11/25/2008US7456286 Bicyclic heteroaromatic compounds as kinase inhibitors
11/25/2008US7456275 Endcapped block polymers including ethylene oxide-propylene oxide, glycolic acid-lactic acid, or ethylene oxide-lactic or glycolic acid; low viscosity allows easy injection; capable of room temperature distribution; extended analgesic effectiveness; nontoxic antiarthritic agents; tissue repair
11/25/2008US7456217 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of multiple sclerosis
11/25/2008US7456198 Useful in the treatment of chronic and acute pain.
11/25/2008US7456190 autoimmune disease; antiinflammatory agents; bone disorders; central nervous system disorders; cardiovascular disorders; Alzheimer's disease; antihistamines; antiallergens
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456157 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/25/2008US7455855 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2433032C Sustained release drug delivery devices with coated drug cores
11/25/2008CA2414146C Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
11/25/2008CA2383212C Controlled release oral dosage suitable for oral administration
11/25/2008CA2376791C Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/25/2008CA2318579C Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
11/25/2008CA2306508C Production of a directly compressible tabletting aid
11/20/2008WO2008141312A1 ((phenyl)imidazolyl)methylheteroaryl compounds
11/20/2008WO2008141249A1 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
11/20/2008WO2008141239A1 Imidazol [1,2-a] pyridines and related compounds with activity at cannabinoid cb2 receptors
11/20/2008WO2008141013A1 S1p3 receptor inhibitors for treating pain
11/20/2008WO2008140750A1 Compounds for modulating trpv3 function
11/20/2008WO2008140421A2 Heterocycloalkyl substituted pyrimidine derivatives
11/20/2008WO2008140420A2 Pyrimidine derivatives
11/20/2008WO2008140419A2 Pyridyl substituted pyrimidine derivatives
11/20/2008WO2008140251A2 Cyclooxygenase-2 inhibitors
11/20/2008WO2008140066A2 Pyridone derivatives as p38a mapk inhibitors
11/20/2008WO2008140041A1 Novel antiphlogistic-analgesic agent
11/20/2008WO2008139879A1 G protein-coupled receptor inhibitor and pharmaceutical product
11/20/2008WO2008139287A1 Azetidine derivatives and their use as prostaglandin e2 antagonists
11/20/2008WO2008139210A2 Process for obtaining steroidal phosphate compounds
11/20/2008WO2008138920A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008WO2008138889A2 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors
11/20/2008WO2008138843A1 Imidazopyridines and triazolopyrimidines useful for the treatment of joint degenerative & inflammatory diseases
11/20/2008WO2008138842A1 Imidazopyrazines and triazolopyrazine for the treatment of joint degenerative and inflammatory diseases
1 ... 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 ... 1272